A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerDevelopment and validation of a prognostic gene-expression signature for lung adenocarcinomaThe interconnectedness of cancer cell signaling.Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary glandSurvival, classifications, and desmosomal plaque genes in non-small cell lung cancer.Temporal Dissection of Rate Limiting Transcriptional Events Using Pol II ChIP and RNA Analysis of Adrenergic Stress Gene Activation.High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationElevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.Identifying gene-gene interactions using penalized tensor regression.Orphan G protein-coupled receptor GPRC5A modulates integrin β1-mediated epithelial cell adhesion.Bladder cancer detection by urinary extracellular vesicle mRNA analysis
P2860
Q24628746-263F7113-52B9-4499-8773-F4D4863AE347Q34412292-97D90CF3-F777-4CAA-90BF-8D71133B02A0Q35669733-569A6A5B-EBEE-4704-8EB7-B3383D0D42E7Q36552489-4FB37F35-3877-4334-9570-20123D644870Q37022284-C88472E7-2003-4F96-802E-9EA268E9494AQ38297247-C366CF3A-070D-4AA2-9978-87A65C52A0A6Q39029780-73440ED3-0F2E-4509-90F1-9782EC0F01DFQ40622697-7AFBB47E-6A1D-44D2-8628-A45816B7E12FQ41879186-2A2A3097-5ED0-47D2-9B74-A53B8DD01234Q42776019-4B9B5B66-CFCA-4E66-8A80-0AB31658771FQ43531437-19CD5BA2-2F89-4FA5-B338-254D085ABE84Q47649108-A90383DF-984D-4B75-9F77-F1D2CD9AAA64Q48316176-CE79BEF0-092B-477F-999A-1317F4E62167Q58697709-243630FA-7288-40C1-9B67-3CBF99D092D4
P2860
A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A Gprc5a tumor suppressor loss ...... in human lung adenocarcinomas
@ast
A Gprc5a tumor suppressor loss ...... in human lung adenocarcinomas
@en
type
label
A Gprc5a tumor suppressor loss ...... in human lung adenocarcinomas
@ast
A Gprc5a tumor suppressor loss ...... in human lung adenocarcinomas
@en
prefLabel
A Gprc5a tumor suppressor loss ...... in human lung adenocarcinomas
@ast
A Gprc5a tumor suppressor loss ...... in human lung adenocarcinomas
@en
P2093
P2860
P356
P1433
P1476
A Gprc5a tumor suppressor loss ...... in human lung adenocarcinomas
@en
P2093
Dafna Lotan
Humam Kadara
Ju-Seog Lee
Junya Fujimoto
Taoyan Men
Xiaofeng Ye
P2860
P304
P356
10.1593/NEO.10390
P50
P577
2010-06-01T00:00:00Z